月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE（每份年报一根整柱，柱宽 = 生效期：报告期 + 4 个月起）
加载中…
获利能力 Profitability (单位：美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率（ROE） | 19.32% | 26.34% | 16.44% | 15.60% | 15.40% | 13.44% | 13.74% | 12.79% | 14.07% | 24.06% | 8.84% | 10.34% | 16.51% | 17.50% | 14.41% | 38.66% | 10.95% | 28.02% | 26.33% | 31.01% | 17.78% | 14.65% |
| 总资产收益率（ROA） | 10.55% | 15.83% | 10.47% | 8.80% | 7.94% | 7.76% | 7.46% | 7.27% | 8.14% | 13.52% | 5.16% | 5.79% | 8.66% | 9.91% | 6.32% | 18.23% | 5.92% | 14.86% | 11.68% | 12.60% | 7.33% | 5.26% |
| 毛利率 | 73.19% | 71.67% | 73.14% | 73.00% | 71.90% | 68.03% | 69.47% | 68.55% | 67.66% | 65.46% | 64.56% | 68.59% | 68.52% | 70.37% | 69.70% | 73.31% | 73.35% | 73.27% | 75.20% | 75.83% | 76.99% | 74.82% |
| 净利率 | 20.52% | 30.73% | 19.33% | 18.74% | 19.33% | 15.57% | 18.05% | 17.63% | 19.17% | 35.31% | 13.55% | 17.75% | 27.36% | 24.11% | 16.17% | 54.62% | 16.00% | 31.83% | 23.08% | 24.64% | 26.82% | 22.52% |
| 每股收益（EPS） | 3.06 | 5.15 | 3.62 | 3.70 | 4.28 | 3.83 | 3.83 | 3.76 | 4.21 | 7.40 | 2.82 | 3.28 | 5.44 | 5.12 | 3.55 | 10.71 | 3.19 | 7.15 | 5.92 | 7.21 | 3.91 | 3.37 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | 11.70% | 17.50% | 2.60% | 3.03% | 6.60% | 4.32% | 6.54% | 5.30% | 10.39% | 3.55% | 5.98% | 6.66% | 9.12% | 9.39% | 7.56% | 9.41% | 6.40% | 13.40% | 11.21% | 10.31% | 6.38% | 6.24% |
| 负债占总资产比率 | 39.28% | 34.53% | 35.58% | 39.83% | 43.42% | 43.88% | 44.23% | 41.01% | 43.50% | 41.38% | 42.45% | 44.22% | 45.94% | 53.07% | 55.65% | 48.54% | 49.41% | 53.22% | 56.84% | 58.04% | 59.72% | 65.63% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | 5.58 | 5.73 | 5.90 | 5.33 | 5.13 | 5.67 | 5.11 | 5.26 | 6.33 | 6.04 | 5.92 | 4.93 | 5.14 | 5.72 | 5.92 | 5.34 | 5.23 | 6.39 | 6.78 | 6.10 | 3.01 | 2.86 |
| 平均收现日数 | 65 天 | 64 天 | 62 天 | 69 天 | 71 天 | 64 天 | 71 天 | 69 天 | 58 天 | 60 天 | 62 天 | 74 天 | 71 天 | 64 天 | 62 天 | 68 天 | 70 天 | 57 天 | 54 天 | 60 天 | 121 天 | 128 天 |
| 固定资产周转率(次) | 0.3182 | 0.3318 | 0.3160 | 0.3180 | 0.3129 | 0.2668 | 0.3300 | 0.3493 | 0.3049 | 0.3233 | 0.3224 | 0.3885 | 0.3501 | 0.2541 | 0.2520 | 0.2699 | 0.2550 | 0.2094 | 0.1880 | 0.1977 | 0.3804 | 0.3882 |
| 总资产周转率 | 50.57% | 50.46% | 52.95% | 46.35% | 41.05% | 49.85% | 41.33% | 41.26% | 41.81% | 37.58% | 37.29% | 31.85% | 30.80% | 40.13% | 38.08% | 32.46% | 35.93% | 45.47% | 49.21% | 49.15% | 26.14% | 22.55% |
现金流量 Cash Flow (单位：亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | 79.55 | 132.01 | 20.38 | 28.94 | 81.34 | 50.75 | 81.19 | 66.87 | 130.23 | 46.74 | 77.77 | 88.60 | 132.71 | 111.12 | 96.58 | 124.07 | 75.17 | 133.93 | 114.59 | 114.35 | 66.56 | 76.16 |
| 净利润 | 71.75 | 119.46 | 81.95 | 84.00 | 97.94 | 91.13 | 92.70 | 91.75 | 102.10 | 177.83 | 67.12 | 77.03 | 126.11 | 117.32 | 80.72 | 240.21 | 69.55 | 148.50 | 119.41 | 139.84 | 76.47 | 64.20 |
| 经营活动现金流量 | 83.04 | 168.09 | 96.64 | 121.91 | 140.67 | 143.09 | 141.94 | 131.74 | 138.97 | 118.97 | 114.75 | 126.21 | 142.72 | 136.25 | 136.50 | 150.71 | 142.36 | 144.58 | 176.19 | 191.44 | 103.09 | 95.58 |
| 投资活动现金流量 | -63.57 | -62.44 | -103.67 | -142.19 | -157.56 | -7.92 | -56.75 | -33.52 | 8.81 | -107.84 | -34.41 | -31.19 | -55.91 | -22.26 | -131.82 | 42.08 | 14.68 | 55.96 | -75.13 | -48.77 | -19.13 | -148.41 |
| 筹资活动现金流量 | -49.31 | -93.18 | -25.73 | 28.09 | 41.16 | -150.24 | -66.75 | -87.69 | -81.47 | -91.76 | -53.14 | -77.33 | -42.44 | -136.27 | -22.08 | -162.64 | -205.62 | -142.78 | -117.42 | -148.67 | -137.61 | 15.59 |
| 净现金流量 | -25.06 | 15.45 | -33.22 | 8.56 | 24.25 | -16.10 | 18.43 | 11.35 | 63.36 | -83.49 | 23.33 | 18.53 | 44.11 | -21.59 | -14.54 | 27.49 | -48.90 | 58.76 | -19.34 | -0.24 | -48.03 | -38.19 |
右侧两列为报告期累计口径同比（左：去年同期同一期次，右：最近一期季报，年报期次已在左侧列展示）；周转率类指标为报告期累计值，未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD